跳至主要内容
临床试验/CTRI/2024/09/073169
CTRI/2024/09/073169尚未招募3 期

An open label non randomised study on the usefulness of individualised homoeopathic medicines in LM potencies vis-a-vis centesimal potencies in the treatment of chronic rhinosinusitis.

Dr Shirin Fabi M1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月7日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
The outcome of treatment will be assessed by the SNOT 22 scoring system.

研究概览

简要总结

The study is an open label non randomised study on the usefulness of individualised homoeopathic medicines in LM potencies vis-a-vis centesimal potencies in chronic rhinosinusitis. Diagnosis of the case will be done by taking a plain xray of paranasal sinuses. Homoeopathic medicines are prescribed according to homoeopathic principles and reviewed every 2 weeks for 4 months. Outcome of treatment will be assessed by SNOT 22 scoring system.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Cases that fulfil the diagnostic criteria.
  • Cases that have a SNOT score above seven.

排除标准

  • Cases with other serious associated illness and life threatening conditions like malignancy.
  • Cases which had undergone surgery for sinusitis.

结局指标

主要结局

The outcome of treatment will be assessed by the SNOT 22 scoring system.

时间窗: The outcome of treatment will be assessed by the SNOT 22 scoring system at the beginning of treatment and after 4 months.

次要结局

  • comparison of usefulness of constitutional homoeopathic medicine in centesimal potency over LM potency.(After 1 year (after completion of study).)

研究者

发起方
Dr Shirin Fabi M
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shirin Fabi M

Govt. Homoeopathic Medical College Kozhikode

研究点 (1)

Loading locations...

相似试验